See more : IC Plus Corp. (8040.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of Alliance Pharma plc (APH.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Alliance Pharma plc, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- i-nexus Global plc (INX.L) Income Statement Analysis – Financial Results
- Abaxx Technologies Inc. (ABXXF) Income Statement Analysis – Financial Results
- Empir Group AB (EMPIR-B.ST) Income Statement Analysis – Financial Results
- Jiangsu Goodwe Power Supply Technology Co., Ltd (688390.SS) Income Statement Analysis – Financial Results
- Kadokawa Corporation (KDKWF) Income Statement Analysis – Financial Results
Alliance Pharma plc (APH.L)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
About Alliance Pharma plc
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 180.68M | 167.42M | 163.21M | 129.80M | 135.64M | 118.21M | 103.32M | 97.49M | 48.34M | 43.54M | 45.51M | 44.90M | 45.96M | 49.88M | 31.24M | 21.76M | 18.22M | 17.25M | 12.28M | 11.83M | 10.42M | 0.00 | 6.34M | 6.12M | 6.27M | 3.76M |
| Cost of Revenue | 75.66M | 65.73M | 53.76M | 46.99M | 49.56M | 45.56M | 44.35M | 42.64M | 19.61M | 18.49M | 18.07M | 19.78M | 21.47M | 19.48M | 13.13M | 10.61M | 9.29M | 8.02M | 5.60M | 5.63M | 5.38M | 0.00 | 4.80M | 4.42M | 4.65M | 2.95M |
| Gross Profit | 105.02M | 101.68M | 109.45M | 82.82M | 86.08M | 72.65M | 58.96M | 54.85M | 28.73M | 25.04M | 27.44M | 25.12M | 24.49M | 30.40M | 18.11M | 11.15M | 8.93M | 9.23M | 6.68M | 6.20M | 5.04M | 0.00 | 1.54M | 1.70M | 1.63M | 808.00K |
| Gross Profit Ratio | 58.12% | 60.74% | 67.06% | 63.80% | 63.46% | 61.46% | 57.07% | 56.26% | 59.43% | 57.52% | 60.29% | 55.95% | 53.28% | 60.94% | 57.98% | 51.22% | 49.02% | 53.50% | 54.37% | 52.44% | 48.38% | 0.00% | 24.31% | 27.74% | 25.94% | 21.49% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 74.00K | 131.00K | 169.00K | 91.00K | 12.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 54.22M | 63.59M | 63.05M | 45.91M | 46.81M | 41.93M | 31.71M | 28.84M | 15.63M | 12.51M | 13.03M | 11.86M | 11.24M | 10.77M | 6.83M | 4.74M | 5.33M | 6.60M | 4.54M | 3.82M | 2.59M | 150.73K | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 54.22M | 63.59M | 63.05M | 45.91M | 46.81M | 41.93M | 31.71M | 28.84M | 15.63M | 12.51M | 13.03M | 11.86M | 11.24M | 10.77M | 6.83M | 4.74M | 5.33M | 6.60M | 4.54M | 3.82M | 2.59M | 150.73K | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 89.24M | 9.29M | 18.68M | 8.53M | 1.82M | 1.79M | 1.45M | 696.00K | 814.00K | 1.06M | 1.05M | 942.00K | 1.06M | 1.06M | 159.00K | -873.00K | -347.00K | 178.00K | 195.00K | 0.00 | 1.51M | -80.26K | 0.00 | 1.54M | 1.47M | 750.00K |
| Operating Expenses | 143.46M | 72.88M | 81.73M | 54.44M | 48.63M | 43.72M | 33.16M | 29.54M | 16.45M | 13.57M | 14.08M | 12.80M | 12.20M | 11.71M | 6.85M | 4.82M | 5.53M | 6.64M | 4.70M | 3.83M | 3.49M | 150.73K | 1.02M | 1.54M | 1.47M | 750.00K |
| Cost & Expenses | 219.12M | 138.61M | 135.48M | 101.43M | 98.19M | 89.28M | 77.51M | 72.18M | 36.06M | 32.06M | 32.15M | 32.58M | 33.67M | 31.19M | 19.98M | 15.43M | 14.82M | 14.66M | 10.30M | 9.46M | 8.87M | 150.73K | 5.82M | 5.96M | 6.11M | 3.70M |
| Interest Income | 113.00K | 16.00K | 23.00K | 10.00K | 23.00K | 52.00K | 104.00K | 111.00K | 139.00K | 48.00K | 2.00K | 0.00 | 2.00K | 7.00K | 2.00K | 21.00K | 17.00K | 16.00K | 61.00K | 162.00K | 35.00K | 80.26K | 0.00 | 1.00K | 10.00K | 37.00K |
| Interest Expense | 9.99M | 4.79M | 3.01M | 2.08M | 3.29M | 3.04M | 2.76M | 3.84M | 1.59M | 986.00K | 1.26M | 1.52M | 1.50M | 1.92M | 2.70M | 3.09M | 2.86M | 2.17M | 1.49M | 1.90M | 1.51M | 1.42M | 187.00K | 35.00K | 16.00K | 1.00K |
| Depreciation & Amortization | 10.33M | 10.76M | 10.11M | 8.91M | 1.68M | 1.55M | 1.39M | 429.00K | 438.00K | 1.42M | 688.00K | 847.00K | 998.00K | 990.00K | 124.00K | 131.00K | 138.00K | 112.00K | 108.00K | 115.00K | 1.83M | 80.26K | 311.00K | 257.00K | 239.00K | 30.00K |
| EBITDA | -28.94M | -6.86M | 31.91M | 24.58M | 36.53M | 27.76M | 32.76M | 25.58M | 16.65M | 12.56M | 13.99M | 13.20M | 13.28M | 16.07M | 8.56M | 5.64M | -213.00K | 2.65M | 2.32M | 2.43M | 225.00K | 1.86M | 672.00K | 418.00K | 411.00K | 125.00K |
| EBITDA Ratio | -16.02% | 12.40% | 26.70% | 37.07% | 28.12% | 32.91% | 26.82% | 27.17% | 26.33% | 30.28% | 30.66% | 29.34% | 28.64% | 38.63% | 36.46% | 25.81% | 17.47% | 15.38% | 16.55% | 22.39% | 24.36% | 0.00% | 13.10% | 6.83% | 6.55% | 3.32% |
| Operating Income | -38.44M | 10.57M | 21.58M | 27.15M | 35.63M | 23.67M | 30.18M | 25.61M | 16.96M | 11.17M | 13.36M | 12.32M | 12.34M | 16.97M | 8.43M | 6.37M | 34.00K | 2.60M | 2.17M | 2.26M | 704.04K | -150.73K | 361.00K | 160.00K | 162.00K | 58.00K |
| Operating Income Ratio | -21.28% | 6.31% | 13.22% | 20.92% | 26.27% | 20.02% | 29.21% | 26.27% | 35.09% | 25.66% | 29.35% | 27.44% | 26.85% | 34.03% | 26.98% | 29.27% | 0.19% | 15.08% | 17.65% | 19.11% | 6.76% | 0.00% | 5.69% | 2.62% | 2.58% | 1.54% |
| Total Other Income/Expenses | -10.36M | -33.62M | -3.42M | -3.30M | -4.55M | -8.05M | 1.98M | -3.39M | 2.90M | -1.32M | -1.35M | -1.51M | -1.63M | -5.82M | -5.52M | -3.95M | -6.95M | -2.11M | -1.51M | -1.85M | -2.86M | -580.27K | -187.00K | -34.00K | -6.00K | 36.00K |
| Income Before Tax | -48.80M | 5.21M | 18.16M | 13.02M | 31.08M | 22.80M | 28.37M | 22.22M | 15.18M | 10.16M | 12.01M | 10.81M | 10.71M | 12.87M | 5.74M | 2.42M | -3.21M | 492.00K | 661.00K | 407.00K | -2.15M | -70.47K | 174.00K | 126.00K | 156.00K | 94.00K |
| Income Before Tax Ratio | -27.01% | 3.11% | 11.13% | 10.03% | 22.91% | 19.29% | 27.46% | 22.79% | 31.40% | 23.33% | 26.39% | 24.08% | 23.31% | 25.81% | 18.38% | 11.14% | -17.61% | 2.85% | 5.38% | 3.44% | -20.67% | 0.00% | 2.74% | 2.06% | 2.49% | 2.50% |
| Income Tax Expense | -15.66M | 4.27M | 10.84M | 4.99M | 6.07M | 4.45M | -541.00K | 4.13M | 2.49M | 1.77M | 2.43M | 2.12M | 2.08M | 3.92M | 1.63M | -87.00K | 3.60M | -11.00K | -45.00K | 273.00K | -197.86K | -80.26K | 230.00K | 34.00K | 6.00K | 1.00K |
| Net Income | -33.14M | 936.00K | 7.32M | 8.03M | 25.01M | 18.36M | 28.91M | 18.09M | 12.69M | 8.39M | 9.58M | 8.69M | 8.64M | 8.95M | 4.11M | 2.51M | -3.21M | 503.00K | 661.00K | 407.00K | -1.96M | -70.47K | -56.00K | 126.00K | 156.00K | 94.00K |
| Net Income Ratio | -18.34% | 0.56% | 4.48% | 6.18% | 18.44% | 15.53% | 27.98% | 18.56% | 26.25% | 19.26% | 21.06% | 19.36% | 18.79% | 17.95% | 13.15% | 11.54% | -17.61% | 2.92% | 5.38% | 3.44% | -18.77% | 0.00% | -0.88% | 2.06% | 2.49% | 2.50% |
| EPS | -0.06 | 0.00 | 0.01 | 0.02 | 0.05 | 0.04 | 0.06 | 0.04 | 0.05 | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 | 0.02 | 0.02 | -0.02 | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 | 0.01 | 0.58 | 0.35 |
| EPS Diluted | -0.06 | 0.00 | 0.01 | 0.01 | 0.05 | 0.04 | 0.06 | 0.04 | 0.05 | 0.03 | 0.04 | 0.03 | 0.03 | 0.04 | 0.02 | 0.01 | -0.02 | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 | 0.01 | 0.58 | 0.35 |
| Weighted Avg Shares Out | 540.14M | 539.48M | 535.30M | 531.06M | 520.69M | 497.20M | 473.84M | 469.42M | 272.73M | 264.15M | 265.01M | 262.97M | 262.82M | 253.96M | 211.91M | 197.78M | 162.06M | 156.66M | 147.36M | 147.36M | 79.97M | 14.96M | 28.12M | 28.12M | 270.00K | 270.00K |
| Weighted Avg Shares Out (Dil) | 540.14M | 545.28M | 542.33M | 537.32M | 530.16M | 510.42M | 479.44M | 474.25M | 279.05M | 265.60M | 265.01M | 262.97M | 262.82M | 253.96M | 211.91M | 197.78M | 162.06M | 156.70M | 147.36M | 147.36M | 79.97M | 14.96M | 28.12M | 28.12M | 270.00K | 270.00K |
No news found for: APH.L
Source: https://incomestatements.info
Category: Stock Reports